Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.549,10
1,05%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Italia BIT Sanofi (1SAN) Sanofi (1SAN) Notizie

Sanofi

1SAN
95,00
3,25 (3,54%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Italia
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
02/5/202407:00GLOBECommuniqué de presse : Des données de vie réelle concernant..
30/4/202418:00GLOBECommuniqué de presse : Assemblée Générale Annuelle du 30..
25/4/202407:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
23/4/202407:00GLOBECommuniqué de presse : L’étude de phase III LUNA 3 du..
17/4/202407:00GLOBEPress Release: New 48-week frexalimab phase 2 data support..
12/4/202420:05GLOBESanofi: Information concerning the total number of voting..
08/4/202418:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/3/202407:30GLOBECommuniqué de presse : Mise en ligne du document «Q1 2024..
15/3/202420:04GLOBESanofi: Information concerning the total number of voting..
11/3/202407:00GLOBEPress Release: New Phase 2b results for amlitelimab support..
24/2/202415:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
23/2/202418:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
23/2/202407:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
22/2/202419:02GLOBEPress Release: Sanofi’s Board of Directors proposes the..
20/2/202423:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/2/202407:00GLOBEPress Release: Japan first in the world to approve Dupixent®..
15/2/202414:00GLOBEPress Release: Phase 2 data published in NEJM show potential..
05/2/202408:00GLOBEPress Release: Peer support, flexible work arrangements,..
01/2/202407:30GLOBECommunique de presse - 2023 : Croissance des ventes et du..
25/1/202420:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
23/1/202407:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
17/1/202422:57GLOBESanofi: Informations relatives au nombre de droits de vote..
09/1/202407:30GLOBEPress Release: Brian Foard appointed Head of Specialty Care..
21/12/202307:30GLOBEPress Release: Sanofi announces end of program evaluating..
18/12/202321:59GLOBESanofi: Informations relatives au nombre de droits de vote..
15/12/202307:30GLOBECommuniqué de presse : Mise en ligne du document «Q4 2023..
15/12/202307:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
11/12/202322:08GLOBEPress Release: Statement on FTC challenge to proposed..
11/12/202301:30GLOBEPress Release: Sarclisa® (isatuximab) plus KRd significantly..
07/12/202307:35GLOBEPress Release: Sarclisa® (isatuximab) Phase 3 trial met..
07/12/202303:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
27/11/202307:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
23/11/202318:00GLOBESanofi: Information concerning the total number of voting..
27/10/202307:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
27/10/202307:30GLOBEPress Release: Sanofi Enters Next Chapter of Play to Win..
22/10/202321:00GLOBECommuniqué de presse : Des résultats de phase III relatifs à..
19/10/202312:00GLOBEPress Release: Sanofi delivers first medicines from Global..
18/10/202310:45GLOBECommuniqué de presse : Des données de ph III présentées au..
17/10/202320:18GLOBESanofi: Informations relatives au nombre de droits de vote..
13/10/202316:00GLOBEPress Release: Late-breaking amlitelimab Phase 2b data..
04/10/202307:00GLOBEPress Release: Sanofi and Teva announce exclusive..
03/10/202307:30GLOBECommuniqué de presse : Sanofi annonce un accord sur un..
26/9/202307:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
25/9/202309:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
22/9/202307:30GLOBECommuniqué de presse : Mise en ligne du document « Q3 2023..
19/9/202308:30GLOBEPress Release: Sanofi supporting vulnerable communities as..
11/9/202320:02GLOBESanofi: Informations relatives au nombre de droits de vote..
31/8/202307:30GLOBECommuniqué de presse: Sanofi annonce des changements au sein..
15/8/202321:24GLOBESanofi: Informations relatives au nombre de droits de vote..
03/8/202321:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..
Apertura: 91,96 Min: 91,87 Max: 91,96
Chiusura: 91,75

La tua Cronologia

BIT
1SAN
Sanofi
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network